Investigative report on FDA enforcement under Trump from Science’s news department shows a steep decline in enforcement actions.
I’ve noticed this, but it is good to see actual data behind it.
I’ll be frank, it would take a lot of data that does not exist to make me feel the companies under the FDA’s oversight have gotten better as a whole. Anecdotally, well there are a lot of less than sterling players out there.
I have mostly questions:
- Have we seen this trend in previous Republican administrations, and is it more pronounced here?
- Is there any evidence that the increase under Obama was a reaction to the previous Republican administration? Are we in a cycle of lax and then tougher enforcement that maybe evens out? That sort of variance is not healthy.
- What, if any data, will we be able to see about impact? There are certainly concerns that the FDA has not done enough. Will this be exacerbated?
- What will it take for this to start affecting the mutual recognition agreements with the EU and other major bodies?